Athira Pharma, INC. (LONA) SEC Filings — 2024
17 SEC filings for Athira Pharma, INC. (LONA) in 2024.
Filings
- Athira Pharma, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Athira Pharma, INC. SC 13G Filing — SC 13G · Nov 7, 2024
- Athira Pharma Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- Perceptive Advisors Amends Athira Pharma Stake — SC 13D/A · Oct 31, 2024
- Athira Pharma Faces Nasdaq Delisting Warning — 8-K · Oct 18, 2024
- Athira Pharma Announces Board, Executive Changes & Compensation — 8-K · Oct 7, 2024
- Athira Pharma CMO Departs, Interim Appointed — 8-K · Sep 17, 2024
- Athira Pharma Files 8-K Report — 8-K · Sep 3, 2024
- Athira Pharma Files 10-Q/A Amendment — 10-Q/A · Aug 9, 2024
- Athira Pharma Files Q2 2024 10-Q — 10-Q · Aug 1, 2024
- Athira Pharma Files 8-K on Shareholder Votes & Financials — 8-K · May 29, 2024
- Athira Pharma Files 8-K — 8-K · May 17, 2024
- Athira Pharma Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- Athira Pharma Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 9, 2024
- Athira Pharma Files 2023 Annual Report on Form 10-K — 10-K · Feb 22, 2024
- Athira Pharma, INC. SC 13G Filing — SC 13G · Feb 14, 2024
- Athira Pharma 8-K: Operations, Officer Changes Reported Jan 4 — 8-K · Jan 8, 2024